Archives: Agenda

• Overcoming inconsistent vendor and CRO budget templates and improving mapping into sponsor financial frameworks
• Defining what a clinical trial budget truly includes, from core operational costs to patient-enabling services
• Streamlining internal approval processes and aligning clinical budgets with broader financial planning and company valuations
• Building stronger financial foundations early to prevent downstream budget misalignment and operational delays

1 seat available for event sponsor

• Designing efficient start-up strategies that optimize timelines and balance speed, cost, and quality in lean biotech environments
• Making critical early decisions on study location, site selection, and operational setup to drive timelines and success
• Strategically aligning clinical plans with financing milestones, ensuring trials generate the right data to support valuation growth
• Building the right operating model by balancing internal capabilities with CRO and FSP partnerships
• Aligning clinical operations with key value inflection points to maximize investor confidence and long-term development impact

• What clinical trial sponsor companies need from vendors to ensure built in quality culture and inspection readiness
• Designing and operationalizing increasingly complex protocols while maintaining efficiency, quality, and patient safety
• Managing the growing matrix of vendors, CROs, and partners to ensure clear accountability, communication, and oversight
• How do you prepare a clinical site for a regulatory inspection for next generational products in research